China to launch fresh pharmaceutical bribery probe - Xinhua
By Kazunori Takada SHANGHAI (Reuters) - China is intensifying its investigation into rampant bribery in the pharmaceutical and medical services sector with a fresh three-month probe slated to begin on Thursday, the official Xinhua news agency reported. The investigation by the State Administration for Industry and Commerce (SAIC), a regulator in charge of market supervision, is aimed at stamping out bribery, fraud and other anti-competitive practices in various sectors, Xinhua said. ...
No comments:
Post a Comment